Cardiac Arrhythmias: Physiological Mechanisms, Clinical Insights, and Epidemiological Research

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (28 February 2025) | Viewed by 2483

Special Issue Editor


E-Mail Website
Guest Editor
Nuffield Department of Medicine, Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
Interests: cardiometabolic diseases; arrhythmias; metabolic syndrome; genetics; epigenomics; molecular epidemiology; genome editing

Special Issue Information

Dear Colleagues,

Cardiac arrhythmias encompass several acquired heart diseases, such as atrial fibrilation, and inherited conditions, such as inherited channelopathies and arrhythmogenic cardiomyopathies. They are a significant cause of mortality and morbidity, representing a major burden to the individual, healthcare system, and society. A body of clinical and epidemiological studies over the past decades has identified several clinical, environmental, social, and genetic factors contributing to the development of arrhythmias. However, there is still a paucity of data on the granular dissection of the mechanisms contributing to arrhythmogenesis. Moreover, current clinical prediction models underperform when deployed in real-world settings.

This Special Issue will focus on the latest developments in pro-arrhythmic mechanisms and how they translate to improved risk stratification of patients and treatment options. The goal is to gather insights from molecular pathways, meta-genomics, single-cell technologies, multimodal approaches, and cellular and in vivo genome editing to refine our understanding of arrhythmogenesis. This Special Issue will also explore novel methods in the molecular epidemiology of cardiac arrhythmias, ranging from propensity score matching, genome-wide association studies, mendelian randomisation through phenome-wide association studies, polygenic prediction models, machine learning models, and natural language models. This Special Issue will span preclinical through clinical research and state-of-the-art reviews.

Dr. Thomas A. Agbaedeng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiac arrhythmias
  • atrial fibrillation
  • sudden cardiac death
  • ventricular arrhythmias
  • electrophysiological remodelling
  • structural remodelling
  • omics
  • risk factors
  • (epi)genetics
  • GWAS
  • PheWas
  • polygenic risk
  • machine learning models
  • natural language models

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

9 pages, 238 KB  
Review
Arrhythmias Following Patent Foramen Ovale Closure: An Unsolved Enigma
by Aikaterini-Eleftheria Karanikola, Stergios Soulaidopoulos, Ioannis Leontsinis, Eirini Dri, Marios Sagris, Athanasios Kordalis, Konstantinos Aznaouridis, Dimitrios Tsiachris and Konstantinos Tsioufis
Life 2024, 14(12), 1590; https://doi.org/10.3390/life14121590 - 2 Dec 2024
Cited by 1 | Viewed by 1993
Abstract
Patent foramen ovale (PFO) closure has proven to be an effective method of reducing the risk of recurrent stroke in patients with embolic stroke of unknown origin (ESUS). One of the most recognized post-procedural complications is the de novo occurrence of supraventricular arrhythmias, [...] Read more.
Patent foramen ovale (PFO) closure has proven to be an effective method of reducing the risk of recurrent stroke in patients with embolic stroke of unknown origin (ESUS). One of the most recognized post-procedural complications is the de novo occurrence of supraventricular arrhythmias, mainly atrial fibrillation, in the first three months following PFO closure. Earlier studies reported the incidence to be around 3.4–7%; however, this percentage has risen in recent studies up to 21%. The pathogenesis behind this type of arrhythmia is complex and not clearly understood, although it seems that direct effects of the device on the atria, as well as an inflammatory response, are the two most prevalent mechanisms. Management of this complication might be challenging given the heterogenicity of patient characteristics, so an individualized approach is most wisely followed. This review aims to present the current data on the incidence, pathogenesis and therapeutic strategies behind this rather common concern in an era of increasing transcatheter interventions for PFO. Full article
Show Figures

Graphical abstract

Back to TopTop